Aquestive Therapeutics
AQST
AQST
35 hedge funds and large institutions have $17M invested in Aquestive Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-2
Holders Change %
-5.41%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
7
Reduced
6
Closed
10
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
-$31K
Top Buyers
| 1 |
Millennium Management
New York
|
+$292K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$133K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$98.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.1K |
| 5 |
Renaissance Technologies
New York
|
+$63.9K |
Top Sellers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$457K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$104K |
| 3 |
Man Group
London,
United Kingdom
|
-$81.1K |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$54.1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$27.3K |
